Report Library
All Reports
Citeline 2015 Pharma R&D Annual Review Report
February 17, 2015
Welcome to Citeline’s 2015 review of trends in pharmaceutical R&D. For around a quarter of a century, Citeline's Ian Lloyd has taken an
annual look at the state of the pharma R&D universe, and compared it to similar data gathered over the many years using Citeline's
Pharmaprojects platform.
In this article, Lloyd looks at how pipeline as a whole has changed in the past twelve months and finds indicators of what the new year
might bring. Keep an eye out for Citeline's review of 2014’s New Active Substance launches which will serve as a supplement to this
report and scheduled to be released at the beginning of March 2015.
In addition, an infographic highlighting key data from the report has also been published.
To download the report, click the PDF link at the top of the page. For more information about Citeline, or to view their other white paper reports, please visit Citeline here.
To download the report, click the PDF link at the top of the page. For more information about Citeline, or to view their other white paper reports, please visit Citeline here.
Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |